Correlating Familial Alzheimer's Disease Gene Mutations with Clinical Phenotype

• Rossor MN , NewmanS, FrackowiakRS, LantosP, KennedyAM: Alzheimer's disease families with amyloid precursor protein mutations.Ann. NY Acad. Sci.695, 198–202 (1993).
   PubMed Web of Science ®Google Scholar
• Goate A , Chartier-HarlinMC, MullanM et al.: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.Nature349(6311) , 704–706 (1991).
   PubMed Web of Science ®Google Scholar
• Sherrington R , RogaevEI, LiangY et al.: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.Nature375(6534) , 754–760 (1995).
   PubMed Web of Science ®Google Scholar
• Levy-Lahad E , WascoW, PoorkajP et al.: Candidate gene for the chromosome 1 familial Alzheimer's disease locus.Science269(5226) , 973–977 (1995).
   PubMed Web of Science ®Google Scholar
• Rovelet-Lecrux A , HannequinD, RauxG et al.: APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy.Nat. Genet.38(1) , 24–26 (2006).
   PubMed Web of Science ®Google Scholar
• Larner AJ , DoranM: Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1gene.J. Neurol.253(2) , 139–158 (2006).
   PubMed Web of Science ®Google Scholar
• Larner AJ , DoranM: Genotype–phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update.J. Alzheimers Dis.17(2) , 259–265 (2009).
   PubMed Web of Science ®Google Scholar
• Selkoe DJ : Alzheimer's disease: genotypes, phenotypes, and treatments.Science275(5300) , 630–631 (1997).
   PubMed Web of Science ®Google Scholar
• Nilsberth C , Westlind-DanielssonA, EckmanCB et al.: The ‘Arctic’ APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation.Nat. Neurosci.4(9) , 887–893 (2001).
   PubMed Web of Science ®Google Scholar
• Holmes C : Genotype and phenotype in Alzheimer's disease.Br. J. Psychiatry180, 131–134 (2002).
   PubMed Web of Science ®Google Scholar
• Godbolt AK , CipolottiL, WattH, FoxNC, JanssenJC, RossorMN: The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort.Arch. Neurol.61(11) , 1743–1748 (2004).
   PubMedGoogle Scholar
• Mann DM , Pickering-BrownSM, TakeuchiA, IwatsuboT: Amyloid angiopathy and variability in amyloid β deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.Am. J. Pathol.158(6) , 2165–2175 (2001).
   PubMed Web of Science ®Google Scholar
• Van Broeckhoven C , BackhovensH, CrutsM et al.: APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease.Neurosci. Lett.169(1–2) , 179–180 (1994).
   PubMed Web of Science ®Google Scholar
• Pastor P , RoeCM, VillegasA et al.: Apolipoprotein Ee4 modifies Alzheimer's disease onset in an E280A PS1 kindred.Ann. Neurol.54(2) , 163–169 (2003).
   PubMed Web of Science ®Google Scholar
• Fox NC , WarringtonEK, SeifferAL, AgnewSK, RossorMN: Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study.Brain121(Pt 9) , 1631–1639 (1998).
   PubMed Web of Science ®Google Scholar
• Warrington EK , AgnewSK, KennedyAM, RossorMN: Neuropsychological profiles of familial Alzheimer's disease associated with mutations in the presenilin 1 and amyloid precursor protein genes.J. Neurol.248(1) , 45–50 (2001).
   PubMed Web of Science ®Google Scholar
• Scahill RI , SchottJM, StevensJM, RossorMN, FoxNC: Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI.Proc. Natl Acad. Sci. USA99(7) , 4703–4707 (2002).
   PubMed Web of Science ®Google Scholar
• Chan D , JanssenJC, WhitwellJL et al.: Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study.Lancet362(9390) , 1121–1122 (2003).
   PubMed Web of Science ®Google Scholar
• Petersen RC , SmithGE, WaringSC, IvnikRJ, TangalosEG, KokmenE: Mild-cognitive impairment: clinical characterization and outcome.Arch. Neurol.56(3) , 303–308 (1999).
   PubMed Web of Science ®Google Scholar
• Godbolt AK , BeckJA, CollingeJ et al.: A presenilin 1 R278I mutation presenting with language impairment.Neurology63(9) , 1702–1704 (2004).
   PubMed Web of Science ®Google Scholar
• Gorno-Tempini ML , BrambatiSM, GinexV et al.: The logopenic/phonological variant of primary progressive aphasia.Neurology71(16) , 1227–1234 (2008).
   PubMed Web of Science ®Google Scholar
• Marcon G , Di FedeG, GiacconeGet al.: A novel Italian presenilin 2 gene mutation with prevalent behavioral phenotype. J. Alzheimers Dis.16(3) , 509–511 (2009).
   PubMed Web of Science ®Google Scholar
• Queralt R , EzquerraM, LleoA et al.: A novel mutation (V89L) in the presenilin 1 gene in a family with early-onset Alzheimer's disease and marked behavioural disturbances.J. Neurol. Neurosurg. Psychiatr.72(2) , 266–269 (2002).
   PubMed Web of Science ®Google Scholar
• Zekanowski C , GolanMP, KrzyskoKA et al.: Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment.Exp. Neurol.200(1) , 82–88 (2006).
   PubMed Web of Science ®Google Scholar
• Rippon GA , CrookR, BakerM et al.: Presenilin 1 mutation in an African American family presenting with atypical Alzheimer dementia.Arch. Neurol.60(6) , 884–888 (2003).
   PubMedGoogle Scholar
• Raux G , GantierR, Thomas-AnterionC et al.: Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation.Neurology55(10) , 1577–1578 (2000).
   PubMed Web of Science ®Google Scholar
• Amtul Z , LewisPA, PiperS et al.: A presenilin 1 mutation associated with familial frontotemporal dementia inhibits γ-secretase cleavage of APP and notch.Neurobiol. Dis.9(2) , 269–273 (2002).
   PubMed Web of Science ®Google Scholar
• Tang-Wai D , LewisP, BoeveB et al.: Familial frontotemporal dementia associated with a novel presenilin-1 mutation.Dement. Geriatr. Cogn. Disord.14(1) , 13–21 (2002).
   PubMed Web of Science ®Google Scholar
• Pickering-Brown SM , BakerM, GassJ et al.: Mutations in progranulin explain atypical phenotypes with variants in MAPT.Brain129(Pt 11) , 3124–3126 (2006).
   PubMed Web of Science ®Google Scholar
• Mendez MF , GhajaraniaM, PerrymanKM: Posterior cortical atrophy: clinical characteristics and differences compared with Alzheimer's disease.Dement. Geriatr. Cogn. Disord.14(1) , 33–40 (2002).
   PubMed Web of Science ®Google Scholar
• Snider BJ , NortonJ, CoatsMA et al.: Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.Arch. Neurol.62(12) , 1821–1830 (2005).
   PubMedGoogle Scholar
• Kennedy AM , NewmanS, McCaddonA et al.: Familial Alzheimer's disease. A pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine–>glycine).Brain116(Pt 2) , 309–324 (1993).
   PubMed Web of Science ®Google Scholar
• Campion D , BriceA, DumanchinC et al.: A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years.Neuroreport7(10) , 1582–1584 (1996).
   PubMed Web of Science ®Google Scholar
• Karlstrom H , BrooksWS, KwokJB et al.: Variable phenotype of Alzheimer's disease with spastic paraparesis.J. Neurochem.104(3) , 573–583 (2008).
   PubMed Web of Science ®Google Scholar
• Assini A , TerreniL, BorghiR et al.: Pure spastic paraparesis associated with a novel presenilin 1 R278K mutation.Neurology60(1) , 150- (2003).
   PubMed Web of Science ®Google Scholar
• Hiltunen M , HelisalmiS, MannermaaA et al.: Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early-onset Alzheimer's disease family: an Alu core sequence-stimulated recombination?.Eur. J. Hum. Genet.8(4) , 259–266 (2000).
   PubMed Web of Science ®Google Scholar
• Verkkoniemi A , SomerM, RinneJO et al.: Variant Alzheimer's disease with spastic paraparesis: clinical characterization.Neurology54(5) , 1103–1109 (2000).
   PubMed Web of Science ®Google Scholar
• O‘Riordan S , McMonagleP, JanssenJC et al.: Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities.Neurology59(7) , 1108–1110 (2002).
   PubMed Web of Science ®Google Scholar
• Houlden H , BakerM, McGowanE et al.: Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-β concentrations.Ann. Neurol.48(5) , 806–808 (2000).
   PubMed Web of Science ®Google Scholar
• Tabira T , ChuiDH, NakayamaH, KurodaS, ShibuyaM: Alzheimer's disease with spastic paresis and cotton wool type plaques.J. Neurosci. Res.70(3) , 367–372 (2002).
   PubMed Web of Science ®Google Scholar
• Yokota O , TeradaS, IshizuH et al.: Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases.Acta Neuropathol.106(4) , 348–356 (2003).
   PubMed Web of Science ®Google Scholar
• Dintchov TL , MehrabianS, Vanden BMet al.: Novel PSEN1 mutation in a bulgarian patient with very early-onset Alzheimer's disease, spastic paraparesis, and extrapyramidal signs.Am. J. Alzheimers Dis. Other Demen.24(5) , 404–407 (2009).
   PubMed Web of Science ®Google Scholar
• Piscopo P , MarconG, PirasMR et al.: A novel PSEN2 mutation associated with a peculiar phenotype.Neurology70(17) , 1549–1554 (2008).
   PubMed Web of Science ®Google Scholar
• Takao M , GhettiB, HayakawaI et al.: A novel mutation (G217D) in the presenilin 1 gene (PSEN1) in a Japanese family: presenile dementia and Parkinsonism are associated with cotton wool plaques in the cortex and striatum.Acta Neuropathol.104(2) , 155–170 (2002).
   PubMed Web of Science ®Google Scholar
• Ishikawa A , PiaoYS, MiyashitaA et al.: A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease.Ann. Neurol.57(3) , 429–434 (2005).
   PubMed Web of Science ®Google Scholar
• Houlden H , CrookR, DolanRJ, McLaughlinJ, ReveszT, HardyJ: A novel presenilin mutation (M233V) causing very early-onset Alzheimer's disease with Lewy bodies.Neurosci. Lett.313(1–2) , 93–95 (2001).
   PubMed Web of Science ®Google Scholar
• Lippa CF , FujiwaraH, MannDM et al.: Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.Am. J. Pathol.153(5) , 1365–1370 (1998).
   PubMed Web of Science ®Google Scholar
• Hamilton RL : Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry.Brain Pathol.10(3) , 378–384 (2000).
   PubMed Web of Science ®Google Scholar
• Leverenz JB , FishelMA, PeskindER et al.: Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype.Arch. Neurol.63(3) , 370–376 (2006).
   PubMedGoogle Scholar
• Cole G , WilliamsP, AlldryckD, SingharoS: Amyloid plaques in the cerebellum in Alzheimer's disease.Clin. Neuropathol.8(4) , 188–191 (1989).
   PubMed Web of Science ®Google Scholar
• Larner AJ : The cerebellum in Alzheimer's disease.Dement. Geriatr. Cogn. Disord.8(4) , 203–209 (1997).
   PubMed Web of Science ®Google Scholar
• Lemere CA , LoperaF, KosikKS et al.: The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology.Nat. Med.2(10) , 1146–1150 (1996).
   PubMed Web of Science ®Google Scholar
• Martin JJ , GheuensJ, BruylandM et al.: Early-onset Alzheimer's disease in 2 large Belgian families.Neurology41(1) , 62–68 (1991).
   PubMed Web of Science ®Google Scholar
• Haltia M , ViitanenM, SulkavaR et al.: Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description.Ann. Neurol.36(3) , 362–367 (1994).
   PubMed Web of Science ®Google Scholar
• Lampe TH , BirdTD, NochlinD et al.: Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred.Ann. Neurol.36(3) , 368–378 (1994).
   PubMed Web of Science ®Google Scholar
• Mann DM , IwatsuboT, IharaY et al.: Predominant deposition of amyloid-β42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.Am. J. Pathol.148(4) , 1257–1266 (1996).
   PubMed Web of Science ®Google Scholar
• Mann DM , JonesD, PrinjaD, PurkissMS: The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.Acta Neuropathol.80(3) , 318–327 (1990).
   PubMed Web of Science ®Google Scholar
• Mann DM , IwatsuboT: Diffuse plaques in the cerebellum and corpus striatum in Down's syndrome contain amyloid β protein (Aβ) only in the form of Aβ42(43).Neurodegeneration5(2) , 115–120 (1996).
   PubMedGoogle Scholar
• Fukutani Y , CairnsNJ, RossorMN, LantosPL: Cerebellar pathology in sporadic and familial Alzheimer's disease including APP 717 (Val-->Ile) mutation cases: a morphometric investigation.J. Neurol. Sci.149(2) , 177–184 (1997).
   PubMed Web of Science ®Google Scholar
• Piccini A , ZanussoG, BorghiR et al.: Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype.Arch. Neurol.64(5) , 738–745 (2007).
   PubMedGoogle Scholar
• Anheim M , HannequinD, BoulayC, MartinC, CampionD, TranchantC: Ataxic variant of Alzheimer's disease caused by Pro117Ala PSEN1 mutation.J. Neurol. Neurosurg. Psychiatr.78(12) , 1414–1415 (2007).
   PubMed Web of Science ®Google Scholar
• Dermaut B , Kumar-SinghS, DeJonghe Cet al.: Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation. Brain124(Pt 12) , 2383–2392 (2001).
   PubMed Web of Science ®Google Scholar
• Yasuda M , MaedaK, IkejiriY, KawamataT, KurodaS, TanakaC: A novel missense mutation in the presenilin-1 gene in a familial Alzheimer's disease pedigree with abundant amyloid angiopathy.Neurosci. Lett.232(1) , 29–32 (1997).
   PubMed Web of Science ®Google Scholar
• Steiner H , ReveszT, NeumannM et al.: A pathogenic presenilin-1 deletion causes abberrant Aβ42 production in the absence of congophilic amyloid plaques.J. Biol. Chem.276(10) , 7233–7239 (2001).
   PubMed Web of Science ®Google Scholar
• Yasuda M , MaedaS, KawamataT et al.: Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy.J. Neurol. Neurosurg. Psychiatr.68(2) , 220–223 (2000).
   PubMed Web of Science ®Google Scholar
• Mullan M , CrawfordF, AxelmanK et al.: A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid.Nat. Genet.1(5) , 345–347 (1992).
   PubMed Web of Science ®Google Scholar
• Van Broeckhoven C , HaanJ, BakkerE et al.: Amyloid β protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch).Science248(4959) , 1120–1122 (1990).
   PubMed Web of Science ®Google Scholar
• Hendriks L , van DuijnCM, CrasPet al.: Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat. Genet.1(3) , 218–221 (1992).
   PubMed Web of Science ®Google Scholar
• Roks G , Van HarskampF, DeKI, et al.: Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). Brain123(Pt 10) , 2130–2140 (2000).
   PubMed Web of Science ®Google Scholar
• Grabowski TJ , ChoHS, VonsattelJP, RebeckGW, GreenbergSM: Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy.Ann. Neurol.49(6) , 697–705 (2001).
   PubMed Web of Science ®Google Scholar
• Basun H , BogdanovicN, IngelssonM et al.: Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease.Arch. Neurol.65(4) , 499–505 (2008).
   PubMedGoogle Scholar
• Guyant-Marechal I , BergerE, LaquerriereA et al.: Intrafamilial diversity of phenotype associated with app duplication.Neurology71(23) , 1925–1926 (2008).
   PubMed Web of Science ®Google Scholar
• Kasuga K , ShimohataT, NishimuraA et al.: Identification of independent APP locus duplication in Japanese patients with early-onset Alzheimer disease.J. Neurol. Neurosurg. Psychiatr.80(9) , 1050–1052 (2009).
   PubMed Web of Science ®Google Scholar
• Schott JM , RidhaBH, CrutchSJ et al.: Apolipoprotein e genotype modifies the phenotype of Alzheimer disease.Arch. Neurol.63(1) , 155–156 (2006).
   PubMedGoogle Scholar
• Harold D , AbrahamR, HollingworthP et al.: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.Nat. Genet.41(10) , 1088–1093 (2009).
   PubMed Web of Science ®Google Scholar
• Lambert JC , HeathS, EvenG et al.: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.Nat. Genet.41(10) , 1094–1099 (2009).
   PubMed Web of Science ®Google Scholar
• Belbin O , BeaumontH, WardenD, SmithAD, KalshekerN, MorganK: PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.Neurobiol. Aging30(12) , 1992–1999 (2009).
   PubMed Web of Science ®Google Scholar
• Beck JA , PoulterM, CampbellTA et al.: Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease.Hum. Mol. Genet.13(12) , 1219–1224 (2004).
   PubMed Web of Science ®Google Scholar
• Weller RO , BocheD, NicollJA: Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.Acta Neuropathol.118(1) , 87–102 (2009).
   PubMed Web of Science ®Google Scholar
• Boche D , ZotovaE, WellerRO et al.: Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brain.Brain131(Pt 12) , 3299–3310 (2008).
   PubMed Web of Science ®Google Scholar
• Dillen K , AnnaertW: A two decade contribution of molecular cell biology to the centennial of Alzheimer's disease: are we progressing towards therapy? In: International Review of Cytology (Volume 254). Jeon KW (Ed.). Elsevier, 215–300 (2006).
   Google Scholar

Website

• Alzheimer Disease and Frontotemporal Dementia Mutation Database www.molgen.ua.ac.be/ADMutations
   Google Scholar